Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Total Debt: 2012-2025

Historic Total Debt for Ptc Therapeutics (PTCT) over the last 11 years, with Sep 2025 value amounting to $286.3 million.

  • Ptc Therapeutics' Total Debt fell 47.24% to $286.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.3 million, marking a year-over-year decrease of 47.24%. This contributed to the annual value of $543.2 million for FY2024, which is 13.52% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Total Debt stood at $286.3 million, which was down 47.76% from $548.0 million recorded in Q2 2025.
  • Ptc Therapeutics' Total Debt's 5-year high stood at $679.0 million during Q3 2023, with a 5-year trough of $286.3 million in Q3 2025.
  • Over the past 3 years, Ptc Therapeutics' median Total Debt value was $542.7 million (recorded in 2024), while the average stood at $546.5 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Total Debt surged by 88.24% in 2023, and later plummeted by 47.24% in 2025.
  • Ptc Therapeutics' Total Debt (Quarterly) stood at $431.4 million in 2021, then soared by 49.24% to $643.9 million in 2022, then decreased by 25.68% to $478.5 million in 2023, then increased by 13.52% to $543.2 million in 2024, then crashed by 47.24% to $286.3 million in 2025.
  • Its Total Debt stands at $286.3 million for Q3 2025, versus $548.0 million for Q2 2025 and $534.0 million for Q1 2025.